Table 4.
Relationship between type of amputation and clinical and laboratory data.
| Variable | Amputation type |
χ2 | p-value | ||
|---|---|---|---|---|---|
| Minor No. (%) | Major No. (%) | Both No. (%) | |||
| Duration of diabetes | 14.63 ± 6.51 | 19.29 ± 10.85 | 17.08 ± 8.08 | 2 | 0.494 |
| White blood cell count | 14.14 ± 7.16 | 20.22 ± 14.13 | 17.28 ± 6.69 | 2 | <0.001 |
| Hemoglobin | 10.4 ± 2.2 | 9.22 ± 2.78 | 9.21 ± 2.14 | 2 | <0.001 |
| HbA1C | 10.23 ± 6.63 | 8.7 ± 2.47 | 8.29 ± 2.12 | 2 | 0.009 |
| Type of diabetes | 5.88 | 0.208 | |||
| Type 1 | 19 (35.8) | 21 (39.6) | 13 (24.5) | ||
| Type 2 | 91 (40.4) | 85 (37.8) | 49 (21.8) | ||
| Oral hypoglycemic agents | 11.56 | 0.021 | |||
| No | 27 (33.8) | 27 (33.8) | 26 (32.5) | ||
| Yes | 63 (44.1) | 54 (37.8) | 26 (18.2) | ||
| Insulin treatment | 11.37 | 0.023 | |||
| No | 30 (35.3) | 39 (45.9) | 16 (18.8) | ||
| Yes | 73 (41.5) | 58 (33) | 45 (25.6) | ||
Participants with lower mean hemoglobin and higher mean creatinine levels constituted a significantly higher percentage of those who died (p < 0.05), as did those who had cardiovascular disease, hypertension, chronic kidney disease, or more than one chronic disease (p < 0.05) (Table 5).